Hikma Seeks To Meet Demand For 503B Compounding In US

CEO Sets Out Strategy For Company’s New Sterile Injectable Compounding Unit

 
• By David Wallace
Compounding bar chart growth green
Hikma expects a “gradual ramp-up” of the compounding business • Source: M-SUR / Alamy Stock Photo

More from Strategy

More from Business